Liposome Drug Delivery Industry Research Report 2024
Summary
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, the global Liposome Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Liposome Drug Delivery by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Liposome Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to APO Research, the global Liposome Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Liposome Drug Delivery is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Liposome Drug Delivery include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Liposome Drug Delivery by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Liposome Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Liposome Drug Delivery Market Size (2019-2030) & (US$ Million)
2.2.2 Global Liposome Drug Delivery Sales (2019-2030)
2.2.3 Global Liposome Drug Delivery Market Average Price (2019-2030)
2.3 Liposome Drug Delivery by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Liposomal Doxorubicin
2.3.3 Liposomal Amphoteracin B
2.3.4 Liposomal Paclitaxel
2.3.5 Others
2.4 Liposome Drug Delivery by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Fungal Infection Therapy
2.4.3 Cancer & Tumor Therapy
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Liposome Drug Delivery Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Liposome Drug Delivery Sales (K Vial) of Manufacturers (2019-2024)
3.3 Global Liposome Drug Delivery Revenue of Manufacturers (2019-2024)
3.4 Global Liposome Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Global Liposome Drug Delivery Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Liposome Drug Delivery, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Liposome Drug Delivery, Product Type & Application
3.8 Global Manufacturers of Liposome Drug Delivery, Date of Enter into This Industry
3.9 Global Liposome Drug Delivery Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Gilead Sciences
4.1.1 Gilead Sciences Company Information
4.1.2 Gilead Sciences Business Overview
4.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
4.1.5 Gilead Sciences Recent Developments
4.2 Pacira
4.2.1 Pacira Company Information
4.2.2 Pacira Business Overview
4.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Pacira Liposome Drug Delivery Product Portfolio
4.2.5 Pacira Recent Developments
4.3 Sun Pharmaceutical
4.3.1 Sun Pharmaceutical Company Information
4.3.2 Sun Pharmaceutical Business Overview
4.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
4.3.5 Sun Pharmaceutical Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Information
4.4.2 Johnson & Johnson Business Overview
4.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
4.4.5 Johnson & Johnson Recent Developments
4.5 Luye Pharma
4.5.1 Luye Pharma Company Information
4.5.2 Luye Pharma Business Overview
4.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
4.5.5 Luye Pharma Recent Developments
4.6 Sigma-Tau
4.6.1 Sigma-Tau Company Information
4.6.2 Sigma-Tau Business Overview
4.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
4.6.5 Sigma-Tau Recent Developments
4.7 Ipsen (Onivyde)
4.7.1 Ipsen (Onivyde) Company Information
4.7.2 Ipsen (Onivyde) Business Overview
4.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
4.7.5 Ipsen (Onivyde) Recent Developments
4.8 CSPC
4.8.1 CSPC Company Information
4.8.2 CSPC Business Overview
4.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.8.4 CSPC Liposome Drug Delivery Product Portfolio
4.8.5 CSPC Recent Developments
4.9 Teva Pharmaceutical
4.9.1 Teva Pharmaceutical Company Information
4.9.2 Teva Pharmaceutical Business Overview
4.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
4.9.5 Teva Pharmaceutical Recent Developments
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Business Overview
4.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Novartis Liposome Drug Delivery Product Portfolio
4.10.5 Novartis Recent Developments
4.11 Fudan-Zhangjiang
4.11.1 Fudan-Zhangjiang Company Information
4.11.2 Fudan-Zhangjiang Business Overview
4.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
4.11.5 Fudan-Zhangjiang Recent Developments
5 GLOBAL LIPOSOME DRUG DELIVERY MARKET SCENARIO BY REGION
5.1 Global Liposome Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Liposome Drug Delivery Sales by Region: 2019-2030
5.2.1 Global Liposome Drug Delivery Sales by Region: 2019-2024
5.2.2 Global Liposome Drug Delivery Sales by Region: 2025-2030
5.3 Global Liposome Drug Delivery Revenue by Region: 2019-2030
5.3.1 Global Liposome Drug Delivery Revenue by Region: 2019-2024
5.3.2 Global Liposome Drug Delivery Revenue by Region: 2025-2030
5.4 North America Liposome Drug Delivery Market Facts & Figures by Country
5.4.1 North America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Liposome Drug Delivery Sales by Country (2019-2030)
5.4.3 North America Liposome Drug Delivery Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Liposome Drug Delivery Market Facts & Figures by Country
5.5.1 Europe Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Liposome Drug Delivery Sales by Country (2019-2030)
5.5.3 Europe Liposome Drug Delivery Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Liposome Drug Delivery Market Facts & Figures by Country
5.6.1 Asia Pacific Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Liposome Drug Delivery Sales by Country (2019-2030)
5.6.3 Asia Pacific Liposome Drug Delivery Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Liposome Drug Delivery Market Facts & Figures by Country
5.7.1 Latin America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Liposome Drug Delivery Sales by Country (2019-2030)
5.7.3 Latin America Liposome Drug Delivery Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
5.8.1 Middle East and Africa Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2030)
5.8.3 Middle East and Africa Liposome Drug Delivery Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Liposome Drug Delivery Sales by Type (2019-2030)
6.1.1 Global Liposome Drug Delivery Sales by Type (2019-2030) & (K Vial)
6.1.2 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
6.2 Global Liposome Drug Delivery Revenue by Type (2019-2030)
6.2.1 Global Liposome Drug Delivery Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
6.3 Global Liposome Drug Delivery Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Liposome Drug Delivery Sales by Application (2019-2030)
7.1.1 Global Liposome Drug Delivery Sales by Application (2019-2030) & (K Vial)
7.1.2 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
7.2 Global Liposome Drug Delivery Revenue by Application (2019-2030)
7.2.1 Global Liposome Drug Delivery Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
7.3 Global Liposome Drug Delivery Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Liposome Drug Delivery Value Chain Analysis
8.1.1 Liposome Drug Delivery Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Liposome Drug Delivery Production Mode & Process
8.2 Liposome Drug Delivery Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Liposome Drug Delivery Distributors
8.2.3 Liposome Drug Delivery Customers
9 GLOBAL LIPOSOME DRUG DELIVERY ANALYZING MARKET DYNAMICS
9.1 Liposome Drug Delivery Industry Trends
9.2 Liposome Drug Delivery Industry Drivers
9.3 Liposome Drug Delivery Industry Opportunities and Challenges
9.4 Liposome Drug Delivery Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Liposome Drug Delivery Market Size (2019-2030) & (US$ Million)
2.2.2 Global Liposome Drug Delivery Sales (2019-2030)
2.2.3 Global Liposome Drug Delivery Market Average Price (2019-2030)
2.3 Liposome Drug Delivery by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Liposomal Doxorubicin
2.3.3 Liposomal Amphoteracin B
2.3.4 Liposomal Paclitaxel
2.3.5 Others
2.4 Liposome Drug Delivery by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Fungal Infection Therapy
2.4.3 Cancer & Tumor Therapy
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Liposome Drug Delivery Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Liposome Drug Delivery Sales (K Vial) of Manufacturers (2019-2024)
3.3 Global Liposome Drug Delivery Revenue of Manufacturers (2019-2024)
3.4 Global Liposome Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Global Liposome Drug Delivery Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Liposome Drug Delivery, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Liposome Drug Delivery, Product Type & Application
3.8 Global Manufacturers of Liposome Drug Delivery, Date of Enter into This Industry
3.9 Global Liposome Drug Delivery Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Gilead Sciences
4.1.1 Gilead Sciences Company Information
4.1.2 Gilead Sciences Business Overview
4.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
4.1.5 Gilead Sciences Recent Developments
4.2 Pacira
4.2.1 Pacira Company Information
4.2.2 Pacira Business Overview
4.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Pacira Liposome Drug Delivery Product Portfolio
4.2.5 Pacira Recent Developments
4.3 Sun Pharmaceutical
4.3.1 Sun Pharmaceutical Company Information
4.3.2 Sun Pharmaceutical Business Overview
4.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
4.3.5 Sun Pharmaceutical Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Information
4.4.2 Johnson & Johnson Business Overview
4.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
4.4.5 Johnson & Johnson Recent Developments
4.5 Luye Pharma
4.5.1 Luye Pharma Company Information
4.5.2 Luye Pharma Business Overview
4.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
4.5.5 Luye Pharma Recent Developments
4.6 Sigma-Tau
4.6.1 Sigma-Tau Company Information
4.6.2 Sigma-Tau Business Overview
4.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
4.6.5 Sigma-Tau Recent Developments
4.7 Ipsen (Onivyde)
4.7.1 Ipsen (Onivyde) Company Information
4.7.2 Ipsen (Onivyde) Business Overview
4.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
4.7.5 Ipsen (Onivyde) Recent Developments
4.8 CSPC
4.8.1 CSPC Company Information
4.8.2 CSPC Business Overview
4.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.8.4 CSPC Liposome Drug Delivery Product Portfolio
4.8.5 CSPC Recent Developments
4.9 Teva Pharmaceutical
4.9.1 Teva Pharmaceutical Company Information
4.9.2 Teva Pharmaceutical Business Overview
4.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
4.9.5 Teva Pharmaceutical Recent Developments
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Business Overview
4.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Novartis Liposome Drug Delivery Product Portfolio
4.10.5 Novartis Recent Developments
4.11 Fudan-Zhangjiang
4.11.1 Fudan-Zhangjiang Company Information
4.11.2 Fudan-Zhangjiang Business Overview
4.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
4.11.5 Fudan-Zhangjiang Recent Developments
5 GLOBAL LIPOSOME DRUG DELIVERY MARKET SCENARIO BY REGION
5.1 Global Liposome Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Liposome Drug Delivery Sales by Region: 2019-2030
5.2.1 Global Liposome Drug Delivery Sales by Region: 2019-2024
5.2.2 Global Liposome Drug Delivery Sales by Region: 2025-2030
5.3 Global Liposome Drug Delivery Revenue by Region: 2019-2030
5.3.1 Global Liposome Drug Delivery Revenue by Region: 2019-2024
5.3.2 Global Liposome Drug Delivery Revenue by Region: 2025-2030
5.4 North America Liposome Drug Delivery Market Facts & Figures by Country
5.4.1 North America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Liposome Drug Delivery Sales by Country (2019-2030)
5.4.3 North America Liposome Drug Delivery Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Liposome Drug Delivery Market Facts & Figures by Country
5.5.1 Europe Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Liposome Drug Delivery Sales by Country (2019-2030)
5.5.3 Europe Liposome Drug Delivery Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Liposome Drug Delivery Market Facts & Figures by Country
5.6.1 Asia Pacific Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Liposome Drug Delivery Sales by Country (2019-2030)
5.6.3 Asia Pacific Liposome Drug Delivery Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Liposome Drug Delivery Market Facts & Figures by Country
5.7.1 Latin America Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Liposome Drug Delivery Sales by Country (2019-2030)
5.7.3 Latin America Liposome Drug Delivery Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
5.8.1 Middle East and Africa Liposome Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2030)
5.8.3 Middle East and Africa Liposome Drug Delivery Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Liposome Drug Delivery Sales by Type (2019-2030)
6.1.1 Global Liposome Drug Delivery Sales by Type (2019-2030) & (K Vial)
6.1.2 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
6.2 Global Liposome Drug Delivery Revenue by Type (2019-2030)
6.2.1 Global Liposome Drug Delivery Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
6.3 Global Liposome Drug Delivery Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Liposome Drug Delivery Sales by Application (2019-2030)
7.1.1 Global Liposome Drug Delivery Sales by Application (2019-2030) & (K Vial)
7.1.2 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
7.2 Global Liposome Drug Delivery Revenue by Application (2019-2030)
7.2.1 Global Liposome Drug Delivery Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
7.3 Global Liposome Drug Delivery Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Liposome Drug Delivery Value Chain Analysis
8.1.1 Liposome Drug Delivery Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Liposome Drug Delivery Production Mode & Process
8.2 Liposome Drug Delivery Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Liposome Drug Delivery Distributors
8.2.3 Liposome Drug Delivery Customers
9 GLOBAL LIPOSOME DRUG DELIVERY ANALYZING MARKET DYNAMICS
9.1 Liposome Drug Delivery Industry Trends
9.2 Liposome Drug Delivery Industry Drivers
9.3 Liposome Drug Delivery Industry Opportunities and Challenges
9.4 Liposome Drug Delivery Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Liposome Drug Delivery Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Liposome Drug Delivery Sales (K Vial) of Manufacturers (2018-2023)
Table 7. Global Liposome Drug Delivery Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Liposome Drug Delivery Revenue of Manufacturers (2018-2023)
Table 9. Global Liposome Drug Delivery Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Liposome Drug Delivery Average Price (USD/Vial) of Manufacturers (2018-2023)
Table 11. Global Liposome Drug Delivery Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Liposome Drug Delivery, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposome Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Gilead Sciences Company Information
Table 17. Gilead Sciences Business Overview
Table 18. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 19. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 20. Gilead Sciences Recent Developments
Table 21. Pacira Company Information
Table 22. Pacira Business Overview
Table 23. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 24. Pacira Liposome Drug Delivery Product Portfolio
Table 25. Pacira Recent Developments
Table 26. Sun Pharmaceutical Company Information
Table 27. Sun Pharmaceutical Business Overview
Table 28. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 29. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 30. Sun Pharmaceutical Recent Developments
Table 31. Johnson & Johnson Company Information
Table 32. Johnson & Johnson Business Overview
Table 33. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 34. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 35. Johnson & Johnson Recent Developments
Table 36. Luye Pharma Company Information
Table 37. Luye Pharma Business Overview
Table 38. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 39. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 40. Luye Pharma Recent Developments
Table 41. Sigma-Tau Company Information
Table 42. Sigma-Tau Business Overview
Table 43. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 44. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 45. Sigma-Tau Recent Developments
Table 46. Ipsen (Onivyde) Company Information
Table 47. Ipsen (Onivyde) Business Overview
Table 48. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 49. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 50. Ipsen (Onivyde) Recent Developments
Table 51. CSPC Company Information
Table 52. CSPC Business Overview
Table 53. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 54. CSPC Liposome Drug Delivery Product Portfolio
Table 55. CSPC Recent Developments
Table 56. Teva Pharmaceutical Company Information
Table 57. Teva Pharmaceutical Business Overview
Table 58. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 59. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 60. Teva Pharmaceutical Recent Developments
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 64. Novartis Liposome Drug Delivery Product Portfolio
Table 65. Novartis Recent Developments
Table 66. Fudan-Zhangjiang Company Information
Table 67. Fudan-Zhangjiang Business Overview
Table 68. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 69. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 70. Fudan-Zhangjiang Recent Developments
Table 71. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 72. Global Liposome Drug Delivery Sales by Region (2018-2023) & (K Vial)
Table 73. Global Liposome Drug Delivery Sales Market Share by Region (2018-2023)
Table 74. Global Liposome Drug Delivery Sales by Region (2024-2029) & (K Vial)
Table 75. Global Liposome Drug Delivery Sales Market Share by Region (2024-2029)
Table 76. Global Liposome Drug Delivery Revenue by Region (2018-2023) & (US$ Million)
Table 77. Global Liposome Drug Delivery Revenue Market Share by Region (2018-2023)
Table 78. Global Liposome Drug Delivery Revenue by Region (2024-2029) & (US$ Million)
Table 79. Global Liposome Drug Delivery Revenue Market Share by Region (2024-2029)
Table 80. North America Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. North America Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 82. North America Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 83. North America Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 84. North America Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 85. Europe Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Europe Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 87. Europe Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 88. Europe Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 89. Europe Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 90. Asia Pacific Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Pacific Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 92. Asia Pacific Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 93. Asia Pacific Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 94. Asia Pacific Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 95. Latin America Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Latin America Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 97. Latin America Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 98. Latin America Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 99. Latin America Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 100. Middle East and Africa Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Middle East and Africa Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 102. Middle East and Africa Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 103. Middle East and Africa Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 105. Global Liposome Drug Delivery Sales by Type (2018-2023) & (K Vial)
Table 106. Global Liposome Drug Delivery Sales by Type (2024-2029) & (K Vial)
Table 107. Global Liposome Drug Delivery Sales Market Share by Type (2018-2023)
Table 108. Global Liposome Drug Delivery Sales Market Share by Type (2024-2029)
Table 109. Global Liposome Drug Delivery Revenue by Type (2018-2023) & (US$ Million)
Table 110. Global Liposome Drug Delivery Revenue by Type (2024-2029) & (US$ Million)
Table 111. Global Liposome Drug Delivery Revenue Market Share by Type (2018-2023)
Table 112. Global Liposome Drug Delivery Revenue Market Share by Type (2024-2029)
Table 113. Global Liposome Drug Delivery Price by Type (2018-2023) & (USD/Vial)
Table 114. Global Liposome Drug Delivery Price by Type (2024-2029) & (USD/Vial)
Table 115. Global Liposome Drug Delivery Sales by Application (2018-2023) & (K Vial)
Table 116. Global Liposome Drug Delivery Sales by Application (2024-2029) & (K Vial)
Table 117. Global Liposome Drug Delivery Sales Market Share by Application (2018-2023)
Table 118. Global Liposome Drug Delivery Sales Market Share by Application (2024-2029)
Table 119. Global Liposome Drug Delivery Revenue by Application (2018-2023) & (US$ Million)
Table 120. Global Liposome Drug Delivery Revenue by Application (2024-2029) & (US$ Million)
Table 121. Global Liposome Drug Delivery Revenue Market Share by Application (2018-2023)
Table 122. Global Liposome Drug Delivery Revenue Market Share by Application (2024-2029)
Table 123. Global Liposome Drug Delivery Price by Application (2018-2023) & (USD/Vial)
Table 124. Global Liposome Drug Delivery Price by Application (2024-2029) & (USD/Vial)
Table 125. Key Raw Materials
Table 126. Raw Materials Key Suppliers
Table 127. Liposome Drug Delivery Distributors List
Table 128. Liposome Drug Delivery Customers List
Table 129. Liposome Drug Delivery Industry Trends
Table 130. Liposome Drug Delivery Industry Drivers
Table 131. Liposome Drug Delivery Industry Restraints
Table 132. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Liposome Drug Delivery Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Liposome Drug Delivery Sales (K Vial) of Manufacturers (2018-2023)
Table 7. Global Liposome Drug Delivery Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Liposome Drug Delivery Revenue of Manufacturers (2018-2023)
Table 9. Global Liposome Drug Delivery Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Liposome Drug Delivery Average Price (USD/Vial) of Manufacturers (2018-2023)
Table 11. Global Liposome Drug Delivery Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Liposome Drug Delivery, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposome Drug Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Gilead Sciences Company Information
Table 17. Gilead Sciences Business Overview
Table 18. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 19. Gilead Sciences Liposome Drug Delivery Product Portfolio
Table 20. Gilead Sciences Recent Developments
Table 21. Pacira Company Information
Table 22. Pacira Business Overview
Table 23. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 24. Pacira Liposome Drug Delivery Product Portfolio
Table 25. Pacira Recent Developments
Table 26. Sun Pharmaceutical Company Information
Table 27. Sun Pharmaceutical Business Overview
Table 28. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 29. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 30. Sun Pharmaceutical Recent Developments
Table 31. Johnson & Johnson Company Information
Table 32. Johnson & Johnson Business Overview
Table 33. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 34. Johnson & Johnson Liposome Drug Delivery Product Portfolio
Table 35. Johnson & Johnson Recent Developments
Table 36. Luye Pharma Company Information
Table 37. Luye Pharma Business Overview
Table 38. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 39. Luye Pharma Liposome Drug Delivery Product Portfolio
Table 40. Luye Pharma Recent Developments
Table 41. Sigma-Tau Company Information
Table 42. Sigma-Tau Business Overview
Table 43. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 44. Sigma-Tau Liposome Drug Delivery Product Portfolio
Table 45. Sigma-Tau Recent Developments
Table 46. Ipsen (Onivyde) Company Information
Table 47. Ipsen (Onivyde) Business Overview
Table 48. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 49. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
Table 50. Ipsen (Onivyde) Recent Developments
Table 51. CSPC Company Information
Table 52. CSPC Business Overview
Table 53. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 54. CSPC Liposome Drug Delivery Product Portfolio
Table 55. CSPC Recent Developments
Table 56. Teva Pharmaceutical Company Information
Table 57. Teva Pharmaceutical Business Overview
Table 58. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 59. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
Table 60. Teva Pharmaceutical Recent Developments
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 64. Novartis Liposome Drug Delivery Product Portfolio
Table 65. Novartis Recent Developments
Table 66. Fudan-Zhangjiang Company Information
Table 67. Fudan-Zhangjiang Business Overview
Table 68. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2018-2023)
Table 69. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
Table 70. Fudan-Zhangjiang Recent Developments
Table 71. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 72. Global Liposome Drug Delivery Sales by Region (2018-2023) & (K Vial)
Table 73. Global Liposome Drug Delivery Sales Market Share by Region (2018-2023)
Table 74. Global Liposome Drug Delivery Sales by Region (2024-2029) & (K Vial)
Table 75. Global Liposome Drug Delivery Sales Market Share by Region (2024-2029)
Table 76. Global Liposome Drug Delivery Revenue by Region (2018-2023) & (US$ Million)
Table 77. Global Liposome Drug Delivery Revenue Market Share by Region (2018-2023)
Table 78. Global Liposome Drug Delivery Revenue by Region (2024-2029) & (US$ Million)
Table 79. Global Liposome Drug Delivery Revenue Market Share by Region (2024-2029)
Table 80. North America Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. North America Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 82. North America Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 83. North America Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 84. North America Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 85. Europe Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Europe Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 87. Europe Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 88. Europe Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 89. Europe Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 90. Asia Pacific Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Pacific Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 92. Asia Pacific Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 93. Asia Pacific Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 94. Asia Pacific Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 95. Latin America Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Latin America Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 97. Latin America Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 98. Latin America Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 99. Latin America Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 100. Middle East and Africa Liposome Drug Delivery Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Middle East and Africa Liposome Drug Delivery Sales by Country (2018-2023) & (K Vial)
Table 102. Middle East and Africa Liposome Drug Delivery Sales by Country (2024-2029) & (K Vial)
Table 103. Middle East and Africa Liposome Drug Delivery Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Liposome Drug Delivery Revenue by Country (2024-2029) & (US$ Million)
Table 105. Global Liposome Drug Delivery Sales by Type (2018-2023) & (K Vial)
Table 106. Global Liposome Drug Delivery Sales by Type (2024-2029) & (K Vial)
Table 107. Global Liposome Drug Delivery Sales Market Share by Type (2018-2023)
Table 108. Global Liposome Drug Delivery Sales Market Share by Type (2024-2029)
Table 109. Global Liposome Drug Delivery Revenue by Type (2018-2023) & (US$ Million)
Table 110. Global Liposome Drug Delivery Revenue by Type (2024-2029) & (US$ Million)
Table 111. Global Liposome Drug Delivery Revenue Market Share by Type (2018-2023)
Table 112. Global Liposome Drug Delivery Revenue Market Share by Type (2024-2029)
Table 113. Global Liposome Drug Delivery Price by Type (2018-2023) & (USD/Vial)
Table 114. Global Liposome Drug Delivery Price by Type (2024-2029) & (USD/Vial)
Table 115. Global Liposome Drug Delivery Sales by Application (2018-2023) & (K Vial)
Table 116. Global Liposome Drug Delivery Sales by Application (2024-2029) & (K Vial)
Table 117. Global Liposome Drug Delivery Sales Market Share by Application (2018-2023)
Table 118. Global Liposome Drug Delivery Sales Market Share by Application (2024-2029)
Table 119. Global Liposome Drug Delivery Revenue by Application (2018-2023) & (US$ Million)
Table 120. Global Liposome Drug Delivery Revenue by Application (2024-2029) & (US$ Million)
Table 121. Global Liposome Drug Delivery Revenue Market Share by Application (2018-2023)
Table 122. Global Liposome Drug Delivery Revenue Market Share by Application (2024-2029)
Table 123. Global Liposome Drug Delivery Price by Application (2018-2023) & (USD/Vial)
Table 124. Global Liposome Drug Delivery Price by Application (2024-2029) & (USD/Vial)
Table 125. Key Raw Materials
Table 126. Raw Materials Key Suppliers
Table 127. Liposome Drug Delivery Distributors List
Table 128. Liposome Drug Delivery Customers List
Table 129. Liposome Drug Delivery Industry Trends
Table 130. Liposome Drug Delivery Industry Drivers
Table 131. Liposome Drug Delivery Industry Restraints
Table 132. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Liposome Drug DeliveryProduct Picture
Figure 5. Global Liposome Drug Delivery Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Liposome Drug Delivery Market Size (2018-2029) & (US$ Million)
Figure 7. Global Liposome Drug Delivery Sales (2018-2029) & (K Vial)
Figure 8. Global Liposome Drug Delivery Average Price (USD/Vial) & (2018-2029)
Figure 9. Liposomal Doxorubicin Product Picture
Figure 10. Liposomal Amphoteracin B Product Picture
Figure 11. Liposomal Paclitaxel Product Picture
Figure 12. Others Product Picture
Figure 13. Fungal Infection Therapy Product Picture
Figure 14. Cancer & Tumor Therapy Product Picture
Figure 15. Others Product Picture
Figure 16. Global Liposome Drug Delivery Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Liposome Drug Delivery, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Liposome Drug Delivery, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Liposome Drug Delivery Sales by Region in 2022
Figure 23. Global Liposome Drug Delivery Revenue by Region in 2022
Figure 24. North America Liposome Drug Delivery Market Size by Country in 2022
Figure 25. North America Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 26. North America Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Liposome Drug Delivery Market Size by Country in 2022
Figure 30. Europe Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 31. Europe Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 32. Germany Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Liposome Drug Delivery Market Size by Country in 2022
Figure 38. Asia Pacific Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 40. China Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Liposome Drug Delivery Market Size by Country in 2022
Figure 50. Latin America Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 51. Latin America Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Liposome Drug Delivery Market Size by Country in 2022
Figure 56. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Liposome Drug Delivery Sales Market Share by Type (2018-2029)
Figure 62. Global Liposome Drug Delivery Revenue Market Share by Type (2018-2029)
Figure 63. Global Liposome Drug Delivery Price (USD/Vial) by Type (2018-2029)
Figure 64. Global Liposome Drug Delivery Sales Market Share by Application (2018-2029)
Figure 65. Global Liposome Drug Delivery Revenue Market Share by Application (2018-2029)
Figure 66. Global Liposome Drug Delivery Price (USD/Vial) by Application (2018-2029)
Figure 67. Liposome Drug Delivery Value Chain
Figure 68. Liposome Drug Delivery Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Liposome Drug Delivery Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Liposome Drug DeliveryProduct Picture
Figure 5. Global Liposome Drug Delivery Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Liposome Drug Delivery Market Size (2018-2029) & (US$ Million)
Figure 7. Global Liposome Drug Delivery Sales (2018-2029) & (K Vial)
Figure 8. Global Liposome Drug Delivery Average Price (USD/Vial) & (2018-2029)
Figure 9. Liposomal Doxorubicin Product Picture
Figure 10. Liposomal Amphoteracin B Product Picture
Figure 11. Liposomal Paclitaxel Product Picture
Figure 12. Others Product Picture
Figure 13. Fungal Infection Therapy Product Picture
Figure 14. Cancer & Tumor Therapy Product Picture
Figure 15. Others Product Picture
Figure 16. Global Liposome Drug Delivery Revenue Share by Manufacturers in 2022
Figure 17. Global Manufacturers of Liposome Drug Delivery, Manufacturing Sites & Headquarters
Figure 18. Global Manufacturers of Liposome Drug Delivery, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2022
Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. Global Liposome Drug Delivery Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. Global Liposome Drug Delivery Sales by Region in 2022
Figure 23. Global Liposome Drug Delivery Revenue by Region in 2022
Figure 24. North America Liposome Drug Delivery Market Size by Country in 2022
Figure 25. North America Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 26. North America Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 27. U.S. Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe Liposome Drug Delivery Market Size by Country in 2022
Figure 30. Europe Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 31. Europe Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 32. Germany Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Liposome Drug Delivery Market Size by Country in 2022
Figure 38. Asia Pacific Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 39. Asia Pacific Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 40. China Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. China Taiwan Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Liposome Drug Delivery Market Size by Country in 2022
Figure 50. Latin America Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 51. Latin America Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East and Africa Liposome Drug Delivery Market Size by Country in 2022
Figure 56. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2018-2029)
Figure 57. Middle East and Africa Liposome Drug Delivery Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Liposome Drug Delivery Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Liposome Drug Delivery Sales Market Share by Type (2018-2029)
Figure 62. Global Liposome Drug Delivery Revenue Market Share by Type (2018-2029)
Figure 63. Global Liposome Drug Delivery Price (USD/Vial) by Type (2018-2029)
Figure 64. Global Liposome Drug Delivery Sales Market Share by Application (2018-2029)
Figure 65. Global Liposome Drug Delivery Revenue Market Share by Application (2018-2029)
Figure 66. Global Liposome Drug Delivery Price (USD/Vial) by Application (2018-2029)
Figure 67. Liposome Drug Delivery Value Chain
Figure 68. Liposome Drug Delivery Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Liposome Drug Delivery Industry Opportunities and Challenges
